← Leaderboards
Richard J Cenedella
A.T. Still University Of Health Sciences
$1,975,986
Attributed
$1,975,986
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,975,986 · 2
By mechanism
R01$1,975,986 · 2
Top collaborators
No co-investigators on record.
Most similar at A.T. Still University Of Health Sciences
Same institution · by research overlap
- Charles R Fleschner$165,503
Others in their field
Top investigators on “Lens”
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$171,224,107
- Michael Cohen-Wolkowiez · Duke University$34,499,656
- Rohit Varma · University Of Southern California$28,661,355
- Ales Cvekl · Yeshiva University$24,388,603
- Thomas J. Grabowski · University Of Iowa$19,645,459
- Warren A Kibbe · Duke University$19,297,527
Research focus
LensLaboratory RatHuman TissueCataractPolymerase Chain ReactionSteroid BiosynthesisX Ray CrystallographyAgingMembrane StructureNucleic Acid ProbesChemical BindingCholesterolGas ChromatographyWestern BlottingsMolecular PathologyDrug Adverse EffectSqualeneAntihypercholesterolemic AgentBinding ProteinsEnzyme InhibitorsGenetic SusceptibilityInfrared SpectrometryLens ProteinsSimvastatin
Grant awards (9)
Lens Cholesterol Metobolism and the U1866A Cataract.$226,250
R01 · FY2005 · EY
Lens Cholesterol Metobolism and the U1866A Cataract.$226,250
R01 · FY2004 · EY
Lens Cholesterol Metobolism and the U1866A Cataract.$226,250
R01 · FY2003 · EY
Lens Cholesterol Metobolism and the U1866A Cataract.$226,250
R01 · FY2002 · EY
LENS MEMBRANE STEROID BINDING PROTEIN (MSRP)$211,697
R01 · FY2002 · EY
Lens Cholesterol Metobolism and the U1866A Cataract.$226,250
R01 · FY2001 · EY
LENS MEMBRANE STEROID BINDING PROTEIN (MSRP)$211,697
R01 · FY2001 · EY
LENS MEMBRANE STEROID BINDING PROTEIN (MSRP)$211,697
R01 · FY2000 · EY
LENS CHOLESTEROL METABOLISM AND THE U18666A CATARACT$209,645
R01 · FY2000 · EY